Dr. Cristea is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Duarte Rd
Duarte, CA 91010Phone+1 626-359-8111Fax+1 626-218-5310
Education & Training
- University of Florida College of Medicine JacksonvilleFellowship, Hematology and Medical Oncology, 1998 - 2000
- Rutgers Health/Monmouth Medical CenterResidency, Internal Medicine, 1995 - 1998
- University of Medicine and Pharmacy ‘Gr T Popa” Iasi Class of 1992
Certifications & Licensure
- NC State Medical License 2000 - Present
- CA State Medical License 2004 - 2024
- FL State Medical License 1999 - 2006
- MI State Medical License 1997 - 1998
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity Start of enrollment: 2009 Jan 01
- Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer Start of enrollment: 2012 Dec 03
- Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer Start of enrollment: 2013 Apr 29
- Join now to see all
Publications & Presentations
PubMed
- 357 citationsOvarian cancer, version 2.2020Deborah K. Armstrong, Ronald D. Alvarez, Jamie N. Bakkum-Gamez, Lisa Barroilhet, Kian Behbakht
Journal of the National Comprehensive Cancer Network. 2021-02-02 - 102 citationsUse and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian CancerLarissa A. Meyer, Angel M. Cronin, Charlotte C. Sun, Kristin Bixel, Michael A. Bookman
Journal of Clinical Oncology. 2016-11-02 - 82 citationsEffective Targeting of TAG72+ Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T Cells.John P. Murad, Anna Kozlowska, Hee Jun Lee, Maya Ramamurthy, Wen-Chung Chang
Frontiers in Immunology. 2018-11-19
Press Mentions
- City of Hope Presents New Cancer Research at American Society of Clinical Oncology MeetingMay 31st, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: